Pharmaceutical compositions and methods for the treatment of cancer

U. Nir; Sally Shpungin; Etai Yaffe; Moshe Cohen

Pharmaceutical compositions and methods for the treatment of cancer

U. Nir (Inventor), Sally Shpungin (Inventor), Etai Yaffe (Inventor), Moshe Cohen (Inventor)

The Mina and Everard Goodman Faculty of Life Sciences - at Bar-Ilan University

Bar-Ilan University

Research output: Patent

Abstract

Provided is a pharmaceutical composition including as an active component a compound of formula (I): Figure US08481572-20130709-C00001 wherein X and (R1)n are as defined, and a physiological acceptable carrier. Also provided is a method for treating cancer including administering to an individual in need of such treatment an effective amount of the presently described pharmaceutical composition.

Original language	English
Patent number	US8481572B2
State	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@misc{17d93b6ca59e4178870fb2288bb92692,

title = "Pharmaceutical compositions and methods for the treatment of cancer",

abstract = "Provided is a pharmaceutical composition including as an active component a compound of formula (I): Figure US08481572-20130709-C00001 wherein X and (R1)n are as defined, and a physiological acceptable carrier. Also provided is a method for treating cancer including administering to an individual in need of such treatment an effective amount of the presently described pharmaceutical composition.",

author = "U. Nir and Sally Shpungin and Etai Yaffe and Moshe Cohen",

note = "EPO- patent No. 08808006.4, Israel-patent No. 203713, USA-patent No. 12/672,157, France-patent No. 08808006.4, Germany-Patent No. 08808006.4, Netherlands-Patent No. 08808006.4, Switzerland-Patent No. 08808006.4, United Kingdom-Patent No. 08808006.4; US8481572B2",

year = "2013",

language = "الإنجليزيّة",

type = "Patent",

}

TY - PAT

T1 - Pharmaceutical compositions and methods for the treatment of cancer

AU - Nir, U.

AU - Shpungin, Sally

AU - Yaffe, Etai

AU - Cohen, Moshe

N1 - EPO- patent No. 08808006.4, Israel-patent No. 203713, USA-patent No. 12/672,157, France-patent No. 08808006.4, Germany-Patent No. 08808006.4, Netherlands-Patent No. 08808006.4, Switzerland-Patent No. 08808006.4, United Kingdom-Patent No. 08808006.4

PY - 2013

Y1 - 2013

N2 - Provided is a pharmaceutical composition including as an active component a compound of formula (I): Figure US08481572-20130709-C00001 wherein X and (R1)n are as defined, and a physiological acceptable carrier. Also provided is a method for treating cancer including administering to an individual in need of such treatment an effective amount of the presently described pharmaceutical composition.

AB - Provided is a pharmaceutical composition including as an active component a compound of formula (I): Figure US08481572-20130709-C00001 wherein X and (R1)n are as defined, and a physiological acceptable carrier. Also provided is a method for treating cancer including administering to an individual in need of such treatment an effective amount of the presently described pharmaceutical composition.

UR - https://patents.google.com/patent/US8481572B2/en

M3 - براءة الإختراع

M1 - US8481572B2

ER -

Pharmaceutical compositions and methods for the treatment of cancer

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this